Wednesday, May 4, 2022

Pfizer: May 2022 Document Release

 


From Public Health and Medical Professionals for Transparency

FDA-CBER-2021-5683-0123168-to-0126026_125742_S1_M5_c4591001-A-D-adva.xptMay 2, 2022163 MBDownload
FDA-CBER-2021-5683-0066701-to-0123167_125742_S1_M5_c4591001-A-D-adfacevd.xptMay 2, 20224 GBDownload
FDA-CBER-2021-5683-0059000 to -0065773_125742_S1_M5_c4591001-A-D-adcevd.xptMay 2, 2022394 MBDownload
FDA CBER 2021 5683 0065774 to 0066700_125742_S1_M5_c4591001 A D addv.xptMay 2, 202244 MBDownload
FDA CBER 2021 5683 0058955 to 0058999_125742_S1_M5_bnt162 01 S define 2 0 0.xslMay 2, 2022183 KBDownload
FDA CBER 2021 5683 0058795 to 0058828_125742_S1_M5_bnt162 01 A define 2 0 0.xslMay 2, 2022183 KBDownload
FDA CBER 2021 5683 0058829 to 0058954_125742_S1_M5_bnt162 01 S define.xmlMay 2, 2022985 KBDownload
FDA CBER 2021 5683 0058615 to 0058652_125742_S1_M5_c4591001 S Supp define.xmlMay 2, 2022300 KBDownload
FDA CBER 2021 5683 0058653 to 0058675_125742_S1_M5_c4591001 S Supp define 2 0 0.xslMay 2, 2022183 KBDownload
FDA CBER 2021 5683 0058676 to 0058794_125742_S1_M5_bnt162 01 A define.xslMay 2, 2022828 KBDownload
FDA CBER 2021 5683 0058595 to 0058614_125742_S1_M5_c4591001 S define 2 0 0.xslMay 2, 2022183 KBDownload
FDA CBER 2021 5683 0058459 to 0058478_125742_S1_M5_c4591001 A Supp define 2 0 0.xslMay 2, 2022183 KBDownload
FDA CBER 2021 5683 0058479 to 0058594_125742_S1_M5_c4591001 S define.xmlMay 2, 2022904 KBDownload
FDA CBER 2021 5683 0058316 to 0058458_125742_S1_M5_c4591001 A Supp define.xmlMay 2, 2022692 KBDownload
125742_S1_M5_CRF_c4591001 1006 10061098.pdfMay 2, 20222 MBDownload
125742_S1_M5_CRF_c4591001 1006 10061176.pdfMay 2, 20223 MBDownload
125742_S1_M5_CRF_c4591001 1006 10061094.pdfMay 2, 20222 MBDownload
125742_S1_M5_CRF_c4591001 1006 10061040.pdfMay 2, 20224 MBDownload
125742_S1_M5_CRF_c4591001 1006 10061052.pdfMay 2, 20222 MBDownload
125742_S1_M5_CRF_c4591001 1006 10061020.pdfMay 2, 20222 MBDownload
125742_S1_M5_CRF_c4591001 1005 10051411.pdfMay 2, 20221 MBDownload
125742_S1_M5_CRF_c4591001 1005 10051387.pdfMay 2, 20222 MBDownload
125742_S1_M5_CRF_c4591001 1005 10051293.pdfMay 2, 20222 MBDownload
125742_S1_M5_CRF_c4591001 1005 10051347.pdfMay 2, 20221 MBDownload
125742_S1_M5_CRF_c4591001 1005 10051214.pdfMay 2, 20221 MBDownload
File NameDate ProducedFile SizeLink
125742_S1_M5_CRF_c4591001 1005 10051054.pdfMay 2, 20222 MBDownload
125742_S1_M5_CRF_c4591001 1005 10051069.pdfMay 2, 20221 MBDownload
125742_S1_M5_CRF_c4591001 1003 10031038.pdfMay 2, 20223 MBDownload
125742_S1_M5_CRF_c4591001 1001 10011100.pdfMay 2, 20222 MBDownload
125742_S1_M5_CRF_c4591001 1001 10011135.pdfMay 2, 20221 MBDownload
125742_S1_M5_CRF_c4591001 1001 10011093.pdfMay 2, 20223 MBDownload
125742_S1_M5_CRF_c4591001 1005 10051047.pdfMay 2, 20221 MBDownload
125742_S1_M5_CRF_c4591001 1003 10031197.pdfMay 2, 20221 MBDownload
125742_S1_M5_CRF_c4591001 1003 10031207.pdfMay 2, 20221 MBDownload
125742_S1_M5_CRF_c4591001 1003 10031186.pdfMay 2, 20222 MBDownload
125742_S1_M5_CRF_c4591001 1003 10031149.pdfMay 2, 20222 MBDownload
125742_S1_M5_CRF_c4591001 1003 10031113.pdfMay 2, 20223 MBDownload
125742_S1_M5_CRF_c4591001 1003 10031111.pdfMay 2, 20222 MBDownload
125742_S1_M5_CRF_c4591001 1003 10031065.pdfMay 2, 20223 MBDownload
125742_S1_M5_bnt162 01 S acrf.pdfMay 2, 20221 MBDownload
125742_S1_M5_bnt162 01 A adrg.pdfMay 2, 2022891 KBDownload
125742_S1_M5_c4591001 S csdrg.pdfMay 2, 20221 MBDownload
125742_S1_M5_c4591001 S Supp acrf.pdfMay 2, 20223 MBDownload
125742_S1_M5_c4591001 S acrf.pdfMay 2, 20223 MBDownload
125742_S1_M5_bnt162 01 S csdrg.pdfMay 2, 20221 MBDownload
125742_S1_M5_5351_c4591001 interim mth6 sponsor signature.pdfMay 2, 202212 MBDownload
125742_S1_M5_5351_c4591001 interim mth6 sample crf.pdfMay 2, 20225 MBDownload
125742_S1_M5_5351_c4591001 interim mth6 randomization sensitive.pdfMay 2, 202265 MBDownload
125742_S1_M5_5351_bnt162 01 interim3 sample crf.pdfMay 2, 20229 MBDownload
125742_S1_M5_5351_bnt162 01 interim3 report body.pdfMay 2, 202242 MBDownload
File NameDate ProducedFile SizeLink
125742_S1_M5_5351_bnt162 01 interim3 protocol deviations.pdfMay 2, 20221 MBDownload
125742_S1_M5_5351_bnt162 01 interim3 protocol.pdfMay 2, 202210 MBDownload
125742_S1_M5_5351_bnt162 01 interim3 patient batches.pdfMay 2, 20223 MBDownload
125742_S1_M5_5351_bnt162 01 interim3 notes for reader.pdfMay 2, 20221 MBDownload
125742_S1_M5_5351_bnt162 01 interim3 synopsis.pdfMay 2, 20224 MBDownload
125742_S1_M5_5351_bnt162 01 interim3 sponsor signature.pdfMay 2, 20222 MBDownload
125742_S1_M5_5351_bnt162 01 interim3 sponsor personnel list.pdfMay 2, 20222 MBDownload
125742_S1_M5_5351_bnt162 01 interim3 sap.pdfMay 2, 20223 MBDownload
125742_S1_M5_5351_bnt162 01 interim3 lab measurements.pdfMay 2, 202291 MBDownload
125742_S1_M5_5351_bnt162 01 interim3 discontinued patients.pdfMay 2, 20222 MBDownload
125742_S1_M5_5351_bnt162 01 interim3 demographics.pdfMay 2, 20222 MBDownload
125742_S1_M5_5351_bnt162 01 interim3 compliance.pdfMay 2, 20227 MBDownload
125742_S1_M5_5351_bnt162 01 interim3 adverse events.pdfMay 2, 20227 MBDownload
125742_S1_M5_5351_bnt162 01 interim3 investigators.pdfMay 2, 20226 MBDownload
125742_S1_M5_5351_bnt162 01 interim3 invest signature.pdfMay 2, 2022634 KBDownload
125742_S1_M5_5351_bnt162 01 interim3 iec irb.pdfMay 2, 20221 MBDownload
125742_S1_M5_5351_bnt162 01 interim3 excluded patients.pdfMay 2, 20222 MBDownload
125742_S1_M5_5351_bnt162 01_10075.pdfMay 2, 20222 MBDownload
125742_S1_M5_5351_bnt162 01_10010.pdfMay 2, 20221 MBDownload
125742_S1_M5_5351_bnt162 01_20215.pdfMay 2, 20222 MBDownload
125742_S1_M5_5351_bnt162 01_20242.pdfMay 2, 20222 MBDownload
125742_S1_M5_5351_bnt162 01_20116.pdfMay 2, 20222 MBDownload

No comments:

Post a Comment